Home/Filings/4/0001596783-22-000142
4//SEC Filing

Flynn Karen 4

Accession 0001596783-22-000142

CIK 0001596783other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 2:31 PM ET

Size

5.1 KB

Accession

0001596783-22-000142

Insider Transaction Report

Form 4
Period: 2022-09-15
Flynn Karen
Pres. Biologics & CCO
Transactions
  • Award

    Common Stock

    2022-09-15+24513,197 total
Footnotes (2)
  • [F1]The equity acquired by the reporting person is the regular, annual grant of restricted stock units (pro-rated to reflect a partial year of service) provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award.
  • [F2]Includes restricted stock units.

Issuer

Catalent, Inc.

CIK 0001596783

Entity typeother

Related Parties

1
  • filerCIK 0001553599

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 2:31 PM ET
Size
5.1 KB